ரிலே சிகிச்சை இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ரிலே சிகிச்சை இன்க். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ரிலே சிகிச்சை இன்க் Today - Breaking & Trending Today

Relay Therapeutics Strengthens Computational Leadership


Relay Therapeutics Strengthens Computational Leadership Team with Addition of Patrick Riley, Ph.D.
Dr. Riley brings extensive experience in artificial intelligence with a focus on drug discovery
May 10, 2021 06:00 ET
| Source:
Relay Therapeutics, Inc.
Relay Therapeutics, Inc.
Cambridge, Massachusetts, UNITED STATES
CAMBRIDGE, Mass., May 10, 2021 (GLOBE NEWSWIRE) Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading edge computational and experimental technologies, today announced the appointment of Patrick Riley, Ph.D., as senior vice president of artificial intelligence. Dr. Riley is an industry expert in artificial intelligence and machine learning, bringing 15 years of experience from Google and extensive knowledge in applying these technologies to drug discovery. Dr. Riley will lead a computational team and ....

United Kingdom , Patrick Riley , Sanjiv Patel , Pat Walters , Relay Therapeutics Inc , Relay Therapeutics , Google Accelerated Science , ஒன்றுபட்டது கிஂக்டம் , பேட்ரிக் ரைலி , சஞ்சீவ் படேல் , பேட் வால்டர்ஸ் , ரிலே சிகிச்சை இன்க் , ரிலே சிகிச்சை , கூகிள் முடுக்கப்பட்ட அறிவியல் ,

Relay Therapeutics Expands Clinical Leadership Team with


Relay Therapeutics Expands Clinical Leadership Team with Addition of Tara O’Meara and Charles Ferté
Ms. O’Meara and Dr. Ferté bring extensive experience in drug development across oncology and genetic disease
May 03, 2021 06:00 ET
| Source:
Relay Therapeutics, Inc.
Relay Therapeutics, Inc.
CAMBRIDGE, Mass., May 03, 2021 (GLOBE NEWSWIRE)
Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading edge computational and experimental technologies, today announced the appointments of Tara O’Meara as senior vice president of clinical development operations, and Charles Ferté, M.D., Ph.D., as vice president, global medical lead for RLY-4008. Ms. O’Meara and Dr. Ferté bring decades of experience in the strategic oversight and execution of multiple drug development programs and will further strengthen the clinical team and Relay The ....

United Kingdom , France General , Dan Budwick , Sanjiv Patel , Pete Rahmer , Sanofi Genzyme , Synageva Biopharma , Tara Omeara , Alexion Pharmaceuticals , Institute Gustave Roussy , Exchange Commission , Early Drug Development , Relay Therapeutics Inc , Genzyme Corporation , Corporate Affairs , Tarao Meara , Charles Fert , Relay Therapeutic , Relay Therapeutics , Private Securities Litigation Reform Act , Relay Therapeutic Annual Report , Vice President , Nasdaq Rlay , Relay Therapeutics , ஒன்றுபட்டது கிஂக்டம் , பிரான்ஸ் ஜநரல் ,